Columbus Research Facility on the Verge of Alzheimer's Game Changer
Pharmaceutical company, Biogen, recently revealed a plan to resurrect its experimental Alzheimer's drug, aducanumab, months after the study's failure and abrupt closure. Biogen beg…
Pharmaceutical company, Biogen, recently revealed a plan to resurrect its experimental Alzheimer's drug, aducanumab, months after the study's failure and abrupt closure. Biogen beg…